Cargando…

The Role of Cannabinoids in the Setting of Cirrhosis

Although the mortality rates of cirrhosis are underestimated, its socioeconomic burden has demonstrated a significant global impact. Cirrhosis is defined by the disruption of normal liver architecture after years of chronic insult by different etiologies. Treatment modalities are recommended primari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dibba, Pratima, Li, Andrew A., Cholankeril, George, Iqbal, Umair, Gadiparthi, Chiranjeevi, Khan, Muhammad Ali, Kim, Donghee, Ahmed, Aijaz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023500/ https://www.ncbi.nlm.nih.gov/pubmed/29890719 http://dx.doi.org/10.3390/medicines5020052

Ejemplares similares

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary
por: Dibba, Pratima, et al.
Publicado: (2019)

Case Report of Isoniazid-Related Acute Liver Failure Requiring Liver Transplantation
por: Li, Andrew A., et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft
por: Liu, Andy, et al.
Publicado: (2018)

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic
por: Kim, Donghee, et al.
Publicado: (2021)

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation
por: Cholankeril, George, et al.
Publicado: (2019)

Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
por: Dibba, Pratima, et al.
Publicado: (2018)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2020)

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
por: Perumpail, Brandon J, et al.
Publicado: (2017)

Hepatitis C in Pregnancy
por: Dibba, Pratima, et al.
Publicado: (2018)

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

When to Initiate Weight Loss Medications in the NAFLD Population
por: Yoo, Eric R., et al.
Publicado: (2018)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
por: Kim, Donghee, et al.
Publicado: (2022)

Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality
por: Kim, Donghee, et al.
Publicado: (2023)

The Role of Vitamin E in the Treatment of NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2018)

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
por: Cholankeril, Rosann, et al.
Publicado: (2018)

Chronic liver disease-related mortality in diabetes before and during the COVID-19 in the United States
por: Kim, Donghee, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies
por: Snyder, Heather S., et al.
Publicado: (2018)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
por: Iqbal, Umair, et al.
Publicado: (2019)

Underutilization of Hepatitis C Virus Seropositive Donor Kidneys in the United States in the Current Opioid Epidemic and Direct-Acting Antiviral Era
por: Li, Andrew A., et al.
Publicado: (2018)

Hemorrhagic Ascites Is Associated With Reduced Survival in Cirrhosis: A Systematic Review and Meta-Analysis
por: Iqbal, Umair, et al.
Publicado: (2022)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019)

High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California
por: Cholankeril, George, et al.
Publicado: (2020)

Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Gandle, Cassandra, et al.
Publicado: (2022)

Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience
por: Aggarwal, Avin, et al.
Publicado: (2017)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
por: Li, Andrew A., et al.
Publicado: (2020)

Role of albumin in cirrhosis: from a hospitalist’s perspective
por: Walayat, Saqib, et al.
Publicado: (2017)

Su1373: UTILIZATION OF DRUG OVERDOSE DONORS FOR LIVER TRANSPLANTATION DURING COVID-19 PANDEMIC
por: Lymberopoulos, Peter, et al.
Publicado: (2022)

Implementation and Impact of Universal Preprocedure Testing of Patients for COVID-19 Before Endoscopy
por: Podboy, Alexander, et al.
Publicado: (2020)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
por: Murag, Soumya, et al.
Publicado: (2021)

Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis
por: Wijarnpreecha, Karn, et al.
Publicado: (2022)

The current trends in the health burden of primary liver cancer across the globe
por: Konyn, Peter, et al.
Publicado: (2023)

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
por: Konyn, Peter, et al.
Publicado: (2023)

The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era
por: Manikat, Richie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s30v8v9vepb7l6peshihhjlcuj